Financial News
Latest News about biotechnology
Recent news which mentions biotechnology
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
May 01, 2024
From CNBC.com News
From CNBC.com News
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
May 01, 2024
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
From CNBC.com News
Walmart to shutter health centers, virtual care service in latest failed push into health care
April 30, 2024
From CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
April 30, 2024
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
From CNBC.com News
‘This is a unique time’: ARK Invest’s chief futurist tackles tech innovation from AI to robotics
April 27, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
From CNBC.com News
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
April 25, 2024
From CNBC.com News
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
April 25, 2024
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.